Droperidol and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Droperidol (droperidol), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Sugammadex, and have Anaesthesia.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Droperidol. It is created by eHealthMe based on reports of 2,447 people who have side effects when taking Droperidol from the FDA, and is updated regularly.

What is Droperidol?

Droperidol has active ingredients of droperidol. eHealthMe is studying from 2,452 Droperidol users. Check the latest studies of Droperidol.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,546 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Aug, 11, 2026

2,447 people reported to have side effects when taking Droperidol.
Among them, 41 people (1.68%) have Hyperhidrosis.

Among these 41 people:

How long have people been on Droperidol when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Droperidol? *

female: 56.1 %
male: 43.9 %

What is the age of people who have Hyperhidrosis when taking Droperidol? *

What are other drugs people take besides Droperidol? *

Sugammadex: 12 people, 29.27%
Paracetamol: 11 people, 26.83%
Midazolam: 10 people, 24.39%
Morphine: 9 people, 21.95%
Fentanyl: 7 people, 17.07%
Haloperidol: 4 people, 9.76%
Lorazepam: 4 people, 9.76%
Ondansetron: 3 people, 7.32%
Ropivacaine Hydrochloride: 3 people, 7.32%
Diazepam: 3 people, 7.32%

What are other side effects people have besides Hyperhidrosis? *

Arrhythmias (irregular heartbeat): 24 people, 58.54%
High Blood Pressure: 17 people, 41.46%
Malaise (a feeling of general discomfort or uneasiness): 15 people, 36.59%
Nosebleed (bleeding from nose): 15 people, 36.59%
Kounis Syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage): 14 people, 34.15%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 14 people, 34.15%
Dyspnea (difficult or laboured breathing): 13 people, 31.71%
Nausea (feeling of having an urge to vomit): 10 people, 24.39%
Stress And Anxiety: 9 people, 21.95%
Dizziness: 8 people, 19.51%

What are the existing conditions these people have? *

Anaesthesia: 15 people, 36.59%
General Anaesthesia: 8 people, 19.51%
Nausea (feeling of having an urge to vomit): 4 people, 9.76%
Pain: 4 people, 9.76%
Neuralgia (pain in one or more nerves): 2 people, 4.88%
Catatonia (unresponsive to external stimuli): 2 people, 4.88%
Nausea And Vomiting: 2 people, 4.88%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 2 people, 4.88%
Stable Angina (a constant chest pain): 1 person, 2.44%
Pneumonia: 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Droperidol and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Droperidol:

Droperidol (2,452 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,546 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on droperidol (the active ingredients of Droperidol) and Droperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.